Last update 19 Dec 2024
Oncostellae SL

Oncostellae SL

Holding Company|
2013|
Spain
|
< 10
|
www.oncostellae.com

Overview

Tags

Digestive System Disorders
Immune System Diseases
Neoplasms
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug3
Chemical drugs1
Top 5 TargetCount
ARK5(NUAK family kinase 1)1
ARK5 x JAK3 x TYK21
JAK3 x MAP3K11 x TYK21
GR(Glucocorticoid receptor)1

Related

4
Drugs associated with Oncostellae SL
OST-122
Target
ARK5 x JAK3 x TYK2
Mechanism
ARK5 inhibitors [+2]
Active Org.
Oncostellae SLOncostellae SL
Originator Org.
Oncostellae SLOncostellae SL
Active Indication
Colitis, Ulcerative
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
OST-664
Target
ARK5
Mechanism
ARK5 inhibitors
Active Org.
Oncostellae SLOncostellae SL
Originator Org.
Oncostellae SLOncostellae SL
Active Indication
Fibrosis
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
OST-246
Target
JAK3 x MAP3K11 x TYK2
Mechanism
JAK3 inhibitors [+2]
Active Org.
Oncostellae SLOncostellae SL
Originator Org.
Oncostellae SLOncostellae SL
Active Indication
Autoimmune Diseases [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Oncostellae SL
NCT04353791 / CompletedPhase 1/2
A Phase Ib/IIa, Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral Treatment With OST-122 in Patients With Moderate to Severe Ulcerative Colitis
100 Clinical Results associated with Oncostellae SL
Login to view more data
0 Patents (Medical) associated with Oncostellae SL
Login to view more data
100 Deals associated with Oncostellae SL
Login to view more data
100 Translational Medicine associated with Oncostellae SL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
OST-122
 ( ARK5 x JAK3 x TYK2 )		Colitis, Ulcerative
More
Phase 1/2
OST-499
 ( GR )		Colorectal Cancer
More
Preclinical
OST-246
 ( JAK3 x MAP3K11 x TYK2 )		Autoimmune Diseases
More
Preclinical
OST-664
 ( ARK5 )		Fibrosis
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free